Unlocking the Therapeutic Potential of Integrin‐Linked Kinase Inhibitors in Bioengineered 3D Breast Tumor Stroma Models
The FASEB Journal · 2026
DOI: 10.1096/fj.202503695r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Salma T Rafik und 3 weiteren Autor:innen. Beteiligte Einrichtung: UCL Centre for 3D Models of Health and Disease, UCL Division of Surgery and Interventional Science, Faculty of Medical Sciences, Charles Bell House, …. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Breast Neoplasms, Tumor Microenvironment, Protein Kinase Inhibitors. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS), Egyptian Cultural and Educational Bureau (ECEB).
Abstract (Originalsprache)
The tumor microenvironment (TME) plays a pivotal role in breast cancer progression and metastasis, and the efficacy of targeted therapies is influenced by the heterogeneous nature of the TME. Interactions between breast cancer cells and their surrounding stromal cells modulate proliferation, invasion, and survival pathways, often via integrin‐mediated mechanotransduction and growth factor signaling. Integrin‐linked kinase (ILK) is a serine/threonine protein kinase that has been widely established as a critical driver of breast cancer progression, metastasis, and therapeutic resistance. Its expression is frequently upregulated in breast cancer tumors and correlates with poor prognosis. Given that ILK activity is highly dependent on cell‐matrix interactions that are only recapitulated in 3D culture, we investigated the effect of an ILK inhibitor in 3D bioengineered compartmentalized breast tumoroid models to better mimic in vivo conditions. Two tumor cell masses (MDA‐MB‐231 or MCF‐7) were cultured within a primary breast tissue stromal compartment representative of breast tissue or a metastatic representative of lung tissue. In highly invasive and highly hypoxic MDA‐MB‐231 3D tumoroid models, ILKI treatment was 2.2 fold more effective in 3D models representative of breast tissue ( p ‐value < 0.0001) compared to those with the metastatic lung compartment ( p ‐value = 0.03). However, ILKI treatment was slightly more effective (1.4 fold) in the less invasive and less hypoxic MCF‐7 3D tumoroid models with the metastatic lung compartment compared to those with the primary breast compartment. Non‐invasive imaging of oxygen gradients in the 3D models shows alleviation of hypoxia following treatment and correlation with enhanced treatment efficacy. These results emphasize the necessity of modeling both the tumor and the stroma since this interaction can directly influence drug efficacy. Moreover, ILK inhibitor treatment holds promise for breast cancer therapy particularly in chemotherapeutic resistant cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UCL Centre for 3D Models of Health and Disease, UCL Division of Surgery and Interventional Science, Faculty of Medical Sciences, Charles Bell House, London, UK.
- Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
ORCID-Profile: Salma T Rafik
Förderung
- Wellcome Trust
- Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS)
- Egyptian Cultural and Educational Bureau (ECEB)
- Wellcome / EPSRC Centre for Interventional and Surgical Sciences
Zitieren
APA
Rafik, S. T., Upadhyay, A., MacRobert, A. J., & Cheema, U. (2026). Unlocking the Therapeutic Potential of Integrin‐Linked Kinase Inhibitors in Bioengineered 3D Breast Tumor Stroma Models. The FASEB Journal. https://doi.org/10.1096/fj.202503695r
Vancouver
Rafik ST, Upadhyay A, MacRobert AJ, Cheema U. Unlocking the Therapeutic Potential of Integrin‐Linked Kinase Inhibitors in Bioengineered 3D Breast Tumor Stroma Models. The FASEB Journal. 2026. doi:10.1096/fj.202503695r
BibTeX
@article{Rafik2026,
author = {Rafik, Salma T and Upadhyay, Anuja and MacRobert, Alexander J and Cheema, Umber},
title = {Unlocking the Therapeutic Potential of Integrin‐Linked Kinase Inhibitors in Bioengineered 3D Breast Tumor Stroma Models},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202503695r}
}
EUVIMED